Differentiation potential of urothelium from patients with benign bladder dysfunction. - Wikidata - awgldk - TriplyDB

Differentiation potential of urothelium from patients with benign bladder dysfunction.

Differentiation potential of urothelium from patients with benign bladder dysfunction.

http://www.wikidata.org/entity/Q35966453

about

Evidence for bladder urothelial pathophysiology in functional bladder disorders Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease Structure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives.ATP during early bladder stretch is important for urgency in detrusor overactivity patients Immunocytochemical characterisation of cultures of human bladder mucosal cells A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease.Aquaporin expression contributes to human transurothelial permeability in vitro and is modulated by NaCl.Differentiation-associated reprogramming of the transforming growth factor β receptor pathway establishes the circuitry for epithelial autocrine/paracrine repair Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression The human urothelial tight junction: claudin 3 and the ZO-1α(+) switch.Increased bladder permeability in interstitial cystitis/painful bladder syndrome.Do mesenchymal stem cells modulate the milieu of reconstructed bladder wall?An examination of regenerative medicine-based strategies for the urinary bladder.Botulinum toxin injection for lower urinary tract dysfunction.FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation.Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.Nerve hyperplasia: a unique feature of ketamine cystitis.Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells Evaluation of gene expression changes in human primary uroepithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites.Primary cultures of human urothelial cells for genotoxicity testing.Differentiation-associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolizing activity of "luminal" muscle-invasive bladder cancers.Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.Perilla extract improves frequent urination in spontaneously hypertensive rats with enhancement of the urothelial presence and anti-inflammatory effects.

P2860

Q26824708-6C126D4B-1D5C-4299-AAA5-DA18A257CABB Q28079052-D000E671-7A65-457D-AC88-DC66A7228D4A Q33558063-D79C1444-54BE-4CAE-829D-511D9BF56C3B Q33757819-B86CD57E-B06A-46E6-A4DB-3F912F085552 Q33874538-338E4C02-2737-4FD9-84C9-B4903310A317 Q34298261-0EE859C4-514F-4191-A0A3-9371A4E08390 Q34427251-39C95AD4-F76A-4DBB-903A-A4D9819E1E59 Q34428811-8020A404-D266-47DB-92D2-730C5017AC76 Q34531854-544CDB21-8819-46A5-B21B-D56ACB647E98 Q35861040-C517366E-FAA3-45BF-AA34-35A4C99550B9 Q35933212-D881664A-D389-4043-956C-EE27B5598A36 Q36445359-95F4FBAD-5106-4966-ABA5-11B10C307657 Q37501897-9DE894D6-2833-47B0-81D3-3C40EB3BA6AD Q37931910-A72D0484-D418-4BBC-AB44-85A89F5263E4 Q38008697-4B9FD34B-926B-4E47-B040-4416E14088FD Q38288442-10C59FB7-1AAF-4CCB-9801-064583106A63 Q40776023-8C7B98E8-BA63-4749-BC4B-7011D199B688 Q41874803-11D10FC8-2B90-4D99-94FF-11C22C155753 Q42315527-DB9C4AEE-E379-4690-AFE9-94EFC64D2B9A Q42714046-998FDEAF-0730-47F4-960A-BDBA985DBDD4 Q46527366-3F2D2A42-D1C7-4E0D-8C66-3F1A2F2980B5 Q48261416-A8AF49E3-0DC8-41B1-B1A8-C60BBD3F6129 Q48439311-B7712132-1B18-4D5B-8644-83FC84D94001 Q52738809-FCF5C625-118A-40E0-952E-969F32651009

P2860

Differentiation potential of urothelium from patients with benign bladder dysfunction.

http://www.wikidata.org/entity/Q35966453

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Differentiation potential of urothelium from patients with benign bladder dysfunction.

@ast

Differentiation potential of urothelium from patients with benign bladder dysfunction.

@en

type

label

Differentiation potential of urothelium from patients with benign bladder dysfunction.

@ast

Differentiation potential of urothelium from patients with benign bladder dysfunction.

@en

prefLabel

Differentiation potential of urothelium from patients with benign bladder dysfunction.

@ast

Differentiation potential of urothelium from patients with benign bladder dysfunction.

@en

P1433

Q35966453-8EF41DFA-A77A-49EA-AAC2-3C8D0B90484A

P1476

Q35966453-F455B53F-4C68-4BA3-B3C6-AEF9C2688370

P2093

Q35966453-10C36836-007E-4B0D-A6D8-1401ECAF846B

Q35966453-11C35F3E-0D3F-4653-B46F-D18F48F1CEB9

Q35966453-12BBCC7E-CC6F-4575-96D9-C50051683CB4

Q35966453-8E665A3B-2AC2-45F4-AC55-8966A0E37600

Q35966453-A37158A6-36CB-4A78-9863-B1D5324A71A3

Q35966453-C50DF902-58F0-4868-AD3C-AE4B5A1824C7

Q35966453-C7B61FE3-1E94-49FD-9963-23A19D06278B

P2860

Q35966453-0448A9EE-CEA0-4167-BB8C-C4D87419E515

Q35966453-08BDA6C4-0BD7-4B85-9DA6-FC0719E669FB

Q35966453-16655B56-91D2-4252-AB7F-9E4BD64415AC

Q35966453-1C301578-AF4D-431F-B332-3A5609706370

Q35966453-1F9B26BD-637B-4822-AA05-F57819D112A9

Q35966453-2B7F29A5-FBED-414C-AF0A-E6B1C596A7E3

Q35966453-370596DB-5F74-4596-8484-0EA64504BF45

Q35966453-45B43C04-193E-4017-B457-4E65D71245AF

Q35966453-52854270-B864-42BB-A914-446D1E755A6A

Q35966453-5A9657E6-A54B-496F-9635-BF4FCEC3C3DB

P304

Q35966453-EF448519-6F7C-495B-95B5-86C4F4DA896E

P31

Q35966453-DE3DC2D3-17D3-412B-88E1-452D114EBFEE

P356

Q35966453-15E733D5-ADA9-4850-B788-924627703B29

P433

Q35966453-E7AB3478-6F65-4B4A-96E8-65D1C6DFAC31

P478

Q35966453-451AD4D9-7EFF-4AE1-9F7B-15F106DD132F

P50

Q35966453-055C3289-0F05-4AAF-9611-48A598FE01E7

P577

Q35966453-343AB1B4-1C8A-46FB-BA9D-4D7DFE94DFF6

P698

Q35966453-E7E33FCD-D7DC-4224-8348-DB67A8E96972

P932

Q35966453-E20D7CE9-51B6-48E5-814A-49BB57DE916D

P356

J.1464-410X.2007.06795.X

P1433

BJU International

P1476

Differentiation potential of urothelium from patients with benign bladder dysfunction.

@en

P2093

Claire L Varley

http://www.w3.org/2001/XMLSchema#string

Fiona Marsh

http://www.w3.org/2001/XMLSchema#string

Ian Eardley

http://www.w3.org/2001/XMLSchema#string

Jennifer Hinley

http://www.w3.org/2001/XMLSchema#string

Jens Stahlschmidt

http://www.w3.org/2001/XMLSchema#string

Ludwik K Trejdosiewicz

http://www.w3.org/2001/XMLSchema#string

Mary A E Garthwaite

http://www.w3.org/2001/XMLSchema#string

P2860

Uroplakin gene expression by normal and neoplastic human urothelium

Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability

Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987.

Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications.

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis.

PPARgamma-regulated tight junction development during human urothelial cytodifferentiation

Interstitial cystitis and pelvic floor dysfunction: a comprehensive review.

A referral center's experience with transitional cell carcinoma misdiagnosed as interstitial cystitis.

Mechanisms of Disease: central nervous system involvement in overactive bladder syndrome.

P304

1506-1516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2007.06795.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Southgate

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17537219

http://www.w3.org/2001/XMLSchema#string

P932

1961637

http://www.w3.org/2001/XMLSchema#string